Table 3.
Variables | β | p-value | η2 (%) | R2 |
---|---|---|---|---|
CDD | 0.027 | 0.023* | 3.5 | 0.05 |
Age | 0.051 | 0.461 | 0.9 | |
CDS | 0.064 | 0.010* | 9.5 | 0.10 |
Age | 0.086 | 0.203 | 3.0 | |
GNG | 0.030 | 0.003* | 7.4 | 0.08 |
Age | 0.097 | 0.179 | 2.9 | |
PRO | 0.040 | 0.002* | 6.9 | 0.08 |
Age | 0.077 | 0.243 | 1.9 | |
SRT1 | 0.007 | 0.267 | 0.8 | 0.02 |
Age | 0.053 | 0.449 | 0.6 | |
SRT2 | 0.010 | 0.071 | 2.7 | 0.04 |
Age | 0.048 | 0.482 | 0.4 | |
SPD | 0.017 | 0.463 | 0.4 | 0.02 |
Age | 0.068 | 0.358 | 2.0 |
β, validity; η2, effect size. DANA Brief subtests: CDD, Code Substitution Delayed; CDS, Code Substitution Simultaneous; GNG, Go/No-Go; PRO, Procedural Reaction Time; SPD, Spatial Discrimination; SRT1, Simple Reaction Time (first administration); SRT2, Simple Reaction Time (second administration);
p < 0.05.